JP Morgan Chase’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.4M | Sell |
703,191
-40,797
| -5% | -$790K | ﹤0.01% | 2363 |
|
|
2025
Q4 | $16M | Buy |
743,988
+74,606
| +11% | +$1.57M | ﹤0.01% | 2256 |
|
|
2025
Q3 | $12.9M | Buy |
669,382
+17,183
| +3% | +$306K | ﹤0.01% | 2500 |
|
|
2025
Q2 | $11.2M | Sell |
652,199
-1,592,233
| -71% | -$67.9M | ﹤0.01% | 2453 |
|
|
2025
Q1 | $143M | Buy |
2,244,432
+223,828
| +11% | +$23.6M | 0.01% | 784 |
|
|
2024
Q4 | $246M | Sell |
2,020,604
-178,279
| -8% | -$21.8M | 0.02% | 593 |
|
|
2024
Q3 | $275M | Buy |
2,198,883
+355,114
| +19% | +$49.1M | 0.02% | 575 |
|
|
2024
Q2 | $291M | Buy |
1,843,769
+15,167
| +0.8% | +$1.95M | 0.03% | 509 |
|
|
2024
Q1 | $237M | Buy |
1,828,602
+526,045
| +40% | +$64.4M | 0.02% | 600 |
|
|
2023
Q4 | $126M | Sell |
1,302,557
-3,305,758
| -72% | -$317M | 0.01% | 787 |
|
|
2023
Q3 | $559M | Buy |
4,608,315
+204,222
| +5% | +$23.1M | 0.07% | 286 |
|
|
2023
Q2 | $504M | Buy |
4,404,093
+701,149
| +19% | +$90.4M | 0.06% | 317 |
|
|
2023
Q1 | $510M | Buy |
3,702,944
+2,459,497
| +198% | +$319M | 0.07% | 308 |
|
|
2022
Q4 | $161M | Buy |
1,243,447
+522,434
| +72% | +$60.5M | 0.02% | 592 |
|
|
2022
Q3 | $79.7M | Sell |
721,013
-302,735
| -30% | -$30.5M | 0.01% | 816 |
|
|
2022
Q2 | $76.7M | Sell |
1,023,748
-66,918
| -6% | -$4.92M | 0.01% | 859 |
|
|
2022
Q1 | $85.2M | Buy |
1,090,666
+42,043
| +4% | +$3.22M | 0.01% | 911 |
|
|
2021
Q4 | $94.4M | Sell |
1,048,623
-464,780
| -31% | -$39.7M | 0.01% | 921 |
|
|
2021
Q3 | $140M | Buy |
1,513,403
+207,061
| +16% | +$15.9M | 0.02% | 711 |
|
|
2021
Q2 | $102M | Buy |
1,306,342
+552,744
| +73% | +$41.9M | 0.01% | 892 |
|
|
2021
Q1 | $56.2M | Sell |
753,598
-1,001
| -0.1% | -$92.4K | 0.01% | 1111 |
|
|
2020
Q4 | $129M | Sell |
754,599
-371,910
| -33% | -$55.1M | 0.02% | 687 |
|
|
2020
Q3 | $159M | Sell |
1,126,509
-451,404
| -29% | -$68.6M | 0.03% | 541 |
|
|
2020
Q2 | $253M | Buy |
1,577,913
+433,450
| +38% | +$59M | 0.05% | 371 |
|
|
2020
Q1 | $112M | Buy |
1,144,463
+207,113
| +22% | +$23.7M | 0.03% | 533 |
|
|
2019
Q4 | $121M | Buy |
937,350
+833,885
| +806% | +$84.2M | 0.02% | 607 |
|
|
2019
Q3 | $7.79M | Buy |
103,465
+5,605
| +6% | +$662K | ﹤0.01% | 2337 |
|
|
2019
Q2 | $12.7M | Sell |
97,860
-116,586
| -54% | -$14.2M | ﹤0.01% | 1904 |
|
|
2019
Q1 | $25.6M | Buy |
214,446
+9,146
| +4% | +$1.18M | 0.01% | 1377 |
|
|
2018
Q4 | $22.4M | Buy |
205,300
+119,377
| +139% | +$14.9M | 0.01% | 1400 |
|
|
2018
Q3 | $13.9M | Sell |
85,923
-115,038
| -57% | -$15.7M | ﹤0.01% | 1932 |
|
|
2018
Q2 | $26.6M | Sell |
200,961
-508,109
| -72% | -$47.9M | 0.01% | 1376 |
|
|
2018
Q1 | $52.5M | Buy |
709,070
+273,841
| +63% | +$18.3M | 0.01% | 909 |
|
|
2017
Q4 | $24.2M | Buy |
435,229
+117,429
| +37% | +$6.22M | 0.01% | 1440 |
|
|
2017
Q3 | $15M | Buy |
317,800
+41,975
| +15% | +$1.68M | ﹤0.01% | 1693 |
|
|
2017
Q2 | $9.3M | Buy |
275,825
+114,300
| +71% | +$3.72M | ﹤0.01% | 2024 |
|
|
2017
Q1 | $4.78M | Buy |
161,525
+98,025
| +154% | +$3.03M | ﹤0.01% | 2461 |
|
|
2016
Q4 | $1.74M | Sell |
63,500
-5,000
| -7% | -$201K | ﹤0.01% | 3153 |
|
|
2016
Q3 | $4.21M | Buy |
68,500
+67,930
| +11,918% | +$2.05M | ﹤0.01% | 2372 |
|
|
2016
Q2 | $11K | Sell |
570
-4,364
| -88% | -$80.8K | ﹤0.01% | 4327 |
|
|
2016
Q1 | $96K | Buy |
4,934
+385
| +8% | +$6.73K | ﹤0.01% | 3764 |
|
|
2015
Q4 | $176K | Buy |
+4,549
| New | +$147K | ﹤0.01% | 3679 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 4269 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 4359 |
|
|
2013
Q4 | – | Sell |
-16,973
| Closed | -$801K | – | 4234 |
|
|
2013
Q3 | $801K | Sell |
16,973
-8,927
| -34% | -$344K | ﹤0.01% | 3395 |
|
|
2013
Q2 | $986K | Buy |
+25,900
| New | +$926K | ﹤0.01% | 3266 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
